Chandigarh, July 16
The Punjab Government has started the process to procure anti-viral drug Remdesivir for treatment of Covid-19 patients.
Dr Rajesh Bhaskar, state's nodal officer for Covid-19, said, the Health Department has sought requisition from three medical colleges in the state. "In the first phase, medicine will be supplied to three government medical colleges. These colleges have expertise and committees in place to decide, which patient requires medicine."
Different studies have indicated that Remdesivir can have adverse effects on kidneys and liver. Even the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences (AIIMS) has advised only emergency use of this medicine. Remdesivir has been issued the 'Emergency Use Authorisation' by the United States Food and Drug Administration for treatment of hospitalised patients with severe Covid-19 illness.
India does not manufacture Remdesivir. So India's drug regulator had last week granted the US pharma giant Gilead Sciences the marketing authorisation for Remdesivir for "restricted emergency use" on hospitalised patients in the country. — TNS
from The Tribune https://ift.tt/3ezof2s
No comments:
Post a Comment